Application of Non-invasive Imaging in Inflammatory Disease Conditions to Evaluate Subclinical Coronary Artery Disease
Overview
Affiliations
Purpose Of Review: Traditional risk models, such as the Framingham risk score, fail to capture the increased cardiovascular disease risk seen in patients with chronic inflammatory diseases. This review will cover imaging modalities and their emerging applications in assessing subclinical cardiovascular disease for both research and clinical care in patients with chronic inflammatory diseases.
Recent Findings: Multiple imaging modalities have been studied to assess for subclinical cardiovascular disease via functional/physiologic, inflammatory, and anatomic assessment in patients with chronic inflammatory diseases. The use of imaging to evaluate subclinical cardiovascular disease in patients with chronic inflammatory diseases has the potential to capture early sub-clinical atherosclerosis, to improve risk stratification of future cardiovascular events, and to guide effective disease management.
Ben Tekaya A, Boukriba S, Fendri A, Rouached L, Saidane O, Bouden S RMD Open. 2022; 8(2).
PMID: 35793876 PMC: 9260841. DOI: 10.1136/rmdopen-2022-002270.
Ben Tekaya A, Mehmli T, Ben Mrad I, Fendri A, Boukriba S, Bouden S Clin Rheumatol. 2022; 41(10):3017-3025.
PMID: 35776282 DOI: 10.1007/s10067-022-06261-5.
Role of Periodontal Infection, Inflammation and Immunity in Atherosclerosis.
Choi H, Dey A, Priyamvara A, Aksentijevich M, Bandyopadhyay D, Dey D Curr Probl Cardiol. 2020; 46(3):100638.
PMID: 32646544 PMC: 8761259. DOI: 10.1016/j.cpcardiol.2020.100638.